Online broker eToro announced today the launch of InvestorAI-US, a portfolio offering exposure to high growth US companies developed in partnership with UK fintech Bridgeweave and powered by its unique AI technology.
Bridgeweave’s proprietary technology ‘InvestorAI’ has adapted computer vision technology used for cancer diagnosis to investing and now crunches over 800 million calculations every day to identify high-growth stocks and analyse their historical performance.
Bruce Keith, CEO at Bridgeweave said:
“Wealth management is being disrupted by changing demand from next-gen digital investors who will transform an underprepared industry. Partnering with eToro, we plan to be at the forefront of this change providing investors with access to the kind of technology and solutions that were previously exclusively…
Read More
